Shaping The Future With Our Investors
Mirxes Holding Co. Ltd.
2629.HK
As Southeast Asia’s first biotech company to list on the HKEX, we are committed to leveraging our proprietary technology, integrated ‘end-to-end’ capabilities, and strong partnerships to accelerate growth in key Asia-Pacific markets and beyond. We invite you to explore this page for financial reports, company announcements, and presentations that underscore our mission to save lives through early detection and drive long-term shareholder value.
Announcements & Circulars
Other Important Information
Featured
A Future Without Late Diagnosis
Harnessing RNA science to detect cancer early and save lives.
Announcement & Circular
Our Technology & Solutions in the Cancer Care Continuum
GASTROClear and LUNGClear in the market, more in the pipeline.
APEX and COMPASS for targeted and comprehensive Next Generation Sequencing (NGS) respectively.
Genomics and bioinformatics services to enhance our partners’ biological system researches.
APEX and COMPASS for targeted and comprehensive Next Generation Sequencing (NGS) respectively.
Genomics and bioinformatics services to enhance our partners’ biological system researches.